Upadacitinib Tablet
Upadacitinib Tablet
Upadacitinib — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
Form: Tablet
Class: Janus Kinase 1 (JAK1) Selective Inhibitor — Immunomodulator
✓ Pan-India Monopoly PCD
✓ Available Now
Pricing, brochure & monopoly territory within 24 hrs.
Upadacitinib Tablet is manufactured and supplied by Trumac Healthcare, a WHO-GMP certified pharmaceutical company in India. This tablet is available for monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing across all Indian states.
Therapeutic Indications
- Moderate to severe rheumatoid arthritis not responding to conventional DMARDs
- Psoriatic arthritis and ankylosing spondylitis
- Moderate to severe atopic dermatitis
- Moderate to severe ulcerative colitis and Crohn's disease
Mechanism of Action
Upadacitinib preferentially inhibits Janus kinase 1 (JAK1), interrupting signalling of several inflammatory cytokines inside immune cells. This dampens the immune-driven inflammation that damages joints, skin and the gut in autoimmune diseases.
Dosage & Administration
- Dosage of Upadacitinib Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
- Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
- Do not exceed the prescribed dose, and complete the full course as advised.
- Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
- To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
- Upper respiratory tract infections
- Shingles (herpes zoster) reactivation
- Acne
- Raised cholesterol, liver enzymes or CPK
- Low white cell or haemoglobin levels
Contraindications
- Serious infections and tuberculosis; screen for TB and hepatitis first
- Risk of heart attack, stroke, blood clots and cancers in high-risk patients
- Contraindicated in pregnancy; use effective contraception
- Avoid live vaccines; not for severe hepatic impairment
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.
PCD Pharma Franchise & Third Party Manufacturing — Upadacitinib Tablet
- ✓ WHO-GMP certified manufacturing — every batch QC released
- ✓ Monopoly PCD franchise rights at district or state level
- ✓ Third party / contract manufacturing under your own brand
- ✓ Wholesale and distributor supply against drug licence + GST
- ✓ Attractive net rates with healthy PTR / PTS margins
- ✓ Dispatch within 48 hours of payment realisation
Composition: Upadacitinib. It is a selective JAK1 inhibitor, used for moderate to severe rheumatoid arthritis not responding to conventional DMARDs and psoriatic arthritis and ankylosing spondylitis. Trumac Healthcare supplies it with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.
PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Upadacitinib Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.
Frequently Asked Questions
Who manufactures Upadacitinib Tablet in India?
Trumac Healthcare is a WHO-GMP certified manufacturer and supplier of Upadacitinib Tablet in India. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.
What is Upadacitinib Tablet used for?
Upadacitinib Tablet is used for moderate to severe rheumatoid arthritis not responding to conventional DMARDs; psoriatic arthritis and ankylosing spondylitis; moderate to severe atopic dermatitis; moderate to severe ulcerative colitis and Crohn's disease. It should be used as advised by a registered medical practitioner.
Is Upadacitinib Tablet available for PCD pharma franchise on monopoly basis?
Yes. Upadacitinib Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.
Do you offer Upadacitinib for third party or contract manufacturing?
Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Upadacitinib Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.
Can Upadacitinib Tablet be supplied on wholesale or distributor basis?
Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.
What is the therapeutic class of Upadacitinib?
Upadacitinib is a selective JAK1 inhibitor (therapeutic class: Janus Kinase 1 (JAK1) Selective Inhibitor — Immunomodulator).
What documentation is provided with each supply?
Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.
How quickly can an order be dispatched?
Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.
Is a prescription required for Upadacitinib Tablet?
Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.
Ready to start your PCD franchise for Upadacitinib Tablet?